Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2009 1
2011 1
2013 1
2014 1
2015 1
2017 1
2018 3
2019 5
2020 4
2021 1
2022 4
2023 4
2024 4
2025 5
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean neeta single (6 results)?
Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
Padmapriyadarsini C, Oswal VS, Jain CD, Mariappan MV, Singla N, Kumar S, Daniel BD, Dave JD, Vadgama P, Ramraj B, Kant S, Bhatnagar AK, Shanmugam S, Paul D, Bharathi J, Palav M, Shah NV, Santhanakrishnan R, Dewan RK, Shekh N, Rathinam P, Sisara AB, Mankar SD, Bajpai J, Mittal U, Chauhan S, Kumar R, Parmar M, Mattoo SK, Jaju J; modified BPaL (mBPaL) Study Team. Padmapriyadarsini C, et al. Among authors: singla n. Clin Infect Dis. 2024 Dec 17;79(6):1375-1385. doi: 10.1093/cid/ciae388. Clin Infect Dis. 2024. PMID: 39194339 Clinical Trial.
Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid.
Daniel BD, Shanmugam S, Mehta R, Bhalla M, Mariappan M, Ramraj B, Awasthi AK, Patel P, Jain A, Jain P, Kumar C, Oswal V, Singla N, Kumar S, Dave J, Vadgama P, Bhatnagar AK, Kant S, Prabhakaran R, Tamakuwala G, Mukherjee RN, Santhanakrishnan RK, Ravikumar D, Nagarajan NK, Kumaravadivelu S, Bharathi J, Sridhar A, Ramachandran R, Matoo SK, Ponnuraja C, Jaju J, Padmapriyadarsini C. Daniel BD, et al. Among authors: singla n. J Infect. 2025 Jul;91(1):106509. doi: 10.1016/j.jinf.2025.106509. Epub 2025 May 15. J Infect. 2025. PMID: 40381662 Free PMC article. Clinical Trial.
PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial.
Singh M, Mehendale S, Guleria R, Sarin R, Tripathy S, Gangakhedkar RR, Katoch K, Pandey RM, Panda S, Pati S, Mohapatra PR, Joshi S, Narasimhaiah S, Kodan P, Bhaskar S, Rani R, Khan AM, Swaminathan S; PreVenTB Trial Team. Singh M, et al. BMJ Open. 2024 Aug 31;14(8):e082916. doi: 10.1136/bmjopen-2023-082916. BMJ Open. 2024. PMID: 39645271 Free article.
Clinico-demographic profile of pre-extensively drug-resistant pulmonary tuberculosis patients in India.
Daniel BD, Muthuvijayalakshmi M, Oswal V, Jain CK, Singla N, Kumar S, Bhatnagar A, Vohra V, Dave J, Bhui NK, Solanki R, Sridhar R, Vadgama P, Suryakant, Prabhakaran R, Ramesh PM, Jeyadeepa B, Kumaravadivelu S, Ramraj B, Jaju J, Padmapriyadarsini C. Daniel BD, et al. Among authors: singla n. Indian J Tuberc. 2025 Oct;72(4):562-565. doi: 10.1016/j.ijtb.2025.04.012. Epub 2025 Apr 30. Indian J Tuberc. 2025. PMID: 40975594
Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study.
Singla R, Khan S, Silsarma A, Chavan V, Mahajan R, Mansoor H, Devan RK, Singla N, Bhalla M, Kumar G, Singh P, Iyer A, Morales M, Devkota SC, Dalal A, Spencer H, Isaakidis P. Singla R, et al. Among authors: singla n. Clin Infect Dis. 2025 Nov 6;81(4):846-852. doi: 10.1093/cid/ciaf068. Clin Infect Dis. 2025. PMID: 40079698 Free PMC article.
Appreciative inquiry and the co-creation of an evaluation framework for Extension for Community Healthcare Outcomes (ECHO) implementation: a two-country experience.
Ghosh S, Struminger BB, Singla N, Roth BM, Kumar A, Anand S, Mtete E, Lusekelo J, Massawe I, Jarpe-Ratner E, Seweryn SM, Risley K, Moonan PK, Pinsker E. Ghosh S, et al. Among authors: singla n. Eval Program Plann. 2022 Jun;92:102067. doi: 10.1016/j.evalprogplan.2022.102067. Epub 2022 Mar 10. Eval Program Plann. 2022. PMID: 35344796 Free PMC article.
34 results